Theralogix, a nationally recognized nutritional science company, announced this week the launch of TheraHemp™, the first enhanced-absorption CBD supplement to be independently tested and certified for content accuracy and purity by NSF® International. TheraHemp successfully completed the rigorous testing and certification process to ensure content accuracy and purity by the public health organization, NSF International.
Commercial production of hemp and CBD products has remained unregulated despite consumer interest, therefore leaving consumers uncertain about the content and purity of many products. NSF International certification assures consumers TheraHemp’s THC content is non-detectable at 100 ppm (0.01%) and contains the exact amount of CBD shown on the label. This is particularly important for individuals subject to drug testing including competitive athletes, first responders, and many individuals holding commercial driver’s licenses.
TheraHemp is formulated with VESIsorb, a patented emulsification agent that enhances absorption and bioavailability. By mimicking the body’s natural process of fat digestion, VESIsorb results in nearly 300% greater overall absorption of CBD. CBD with VESIsorb also results in three times faster absorption than its competitors, with peak CBD blood levels reached in one hour.
Each TheraHemp softgel provides broad-spectrum hemp oil and is standardized to provide 20 mg of CBD along with 8 mg of beta-caryophyllene-enriched terpenes. TheraHemp is also dye-free and gluten-free. TheraHemp is available at $98 MSRP for a 60-count bottle. In addition, NSF certification ensures each CBD softgel contains the dose listed on the label, is certified gluten-free and does not contain contaminants. NSF certification is the best guarantee to ensure you are getting pure and accurate cannabinoid and terpene content.
Theralogix was founded in 2002 by a team of physicians and scientists committed to developing evidence-based, independently certified micronutrient supplements. Theralogix products have been used in over a dozen clinical trials conducted by esteemed universities and research institutions across the United States. Theralogix has a full line of products for specialty uses including rheumatology, women’s health, urology, and fertility health. Each product has been approved by their Medical Advisory Board which is comprised of physicians, nationally reputed scientists, and faculty members from leading U.S. medical schools.
